| Literature DB >> 30182916 |
Clarence C Tam1,2, Kathryn B Anderson3, Vittoria Offeddu2, Alden Weg4, Louis R Macareo4, Damon W Ellison4, Ram Rangsin5, Stefan Fernandez4, Robert V Gibbons6, In-Kyu Yoon4, Sriluck Simasathien7.
Abstract
Military recruits are at high risk of respiratory infections. However, limited data exist on military populations in tropical settings, where the epidemiology of respiratory infections differs substantially from temperate settings. We enrolled recruits undertaking a 10-week military training at two Royal Thai Army barracks between May 2014 and July 2015. We used a multiplex respiratory panel to analyze nose and throat swabs collected at the start and end of the training period, and from participants experiencing respiratory symptoms during follow-up. Paired sera were tested for influenza seroconversion using a hemagglutinin inhibition assay. Overall rates of upper respiratory illness and influenza-like illness were 3.1 and 2.0 episodes per 100 person-weeks, respectively. A pathogen was detected in 96% of samples. The most commonly detected microbes were Haemophilus influenzae type B (62.7%) or non-type B (58.2%) and rhinovirus (22.4%). At baseline, bacterial colonization was high and included H. influenzae type B (82.3%), H. influenzae non-type B (31.5%), Klebsiella pneumoniae (14.6%), Staphylococcus aureus (8.5%), and Streptococcus pneumoniae (8.5%). At the end of follow-up, colonization with H. influenzae non-type B had increased to 74.1%, and S. pneumoniae to 33.6%. In the serology subset, the rate of influenza infection was 3.4 per 100 person-months; 58% of influenza infections resulted in clinical disease. Our study provides key data on the epidemiology and transmission of respiratory pathogens in tropical settings. Our results emphasize the need for improved infection prevention and control in military environments, given the high burden of illness and potential for intense transmission of respiratory pathogens.Entities:
Mesh:
Year: 2018 PMID: 30182916 PMCID: PMC6159564 DOI: 10.4269/ajtmh.18-0219
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345
Figure 1.Rates of upper respiratory illness (URI) by cohort in camp A (blue boxes) and camp B (orange boxes). The area of boxes is proportional to the size of each cohort. Gray lines indicate 95% confidence intervals. No URI cases were detected in camp A during the May 2014 training period. This figure appears in color at
Distribution of symptoms in URI and ILI cases among Royal Thai Army recruits
| Symptom | URI ( | ILI ( | Non-ILI ( | ||||
|---|---|---|---|---|---|---|---|
| Number | (%) | Number | (%) | Number | (%) | ||
| Fever | 160 | 64.5 | 160 | 100.0 | 0 | 0.0 | < 0.001 |
| Cough | 236 | 95.2 | 157 | 98.1 | 79 | 89.8 | 0.005 |
| Sore throat | 232 | 93.5 | 156 | 97.5 | 76 | 86.4 | 0.002 |
| Nasal congestion | 204 | 82.3 | 154 | 96.3 | 50 | 56.8 | < 0.001 |
| Headache | 209 | 84.3 | 146 | 91.3 | 63 | 71.6 | < 0.001 |
| Malaise | 171 | 69.0 | 143 | 89.4 | 28 | 31.8 | < 0.001 |
| Breathing difficulty | 156 | 62.9 | 139 | 86.9 | 17 | 19.3 | < 0.001 |
| Muscle ache | 141 | 56.9 | 136 | 85.0 | 5 | 5.7 | < 0.001 |
| Tonsillitis | 55 | 22.2 | 50 | 31.3 | 5 | 5.7 | < 0.001 |
| Swollen lymph nodes | 50 | 20.1 | 43 | 26.9 | 7 | 8.0 | < 0.001 |
| Paralysis | 42 | 16.9 | 40 | 25.0 | 2 | 2.3 | < 0.001 |
| Chills | 37 | 14.9 | 36 | 22.5 | 1 | 1.1 | < 0.001 |
| Diarrhea | 16 | 6.5 | 14 | 8.8 | 2 | 2.3 | 0.058 |
| Stiffness | 1 | 0.4 | 1 | 0.6 | 0 | 0.0 | 1.000 |
| Vision or hearing loss | 1 | 0.4 | 1 | 0.6 | 0 | 0.0 | 1.000 |
| Impact on daily duties: | |||||||
| Stopped working | 104 | 41.9 | 92 | 57.5 | 12 | 13.6 | < 0.001 |
| Assigned lighter duties | 71 | 28.6 | 38 | 23.8 | 33 | 37.5 | – |
| Days off work (median [IQR | 0 (0–1) | – | 1 (0–1) | – | – | – | < 0.001 |
ILI = influenza-like illness; URI = upper respiratory illness.
Fisher’s exact test comparing ILI and non-ILI cases.
IQR = interquartile range.
Distribution of respiratory pathogens in a subset of URI and ILI cases among Royal Thai Army recruits tested by Fast Track multiplex respiratory panel (FTD33)
| Pathogen type | URI ( | ILI ( | Non-ILI ( | |||||
|---|---|---|---|---|---|---|---|---|
| Pathogen | Positive | % | Positive | % | Positive | % | ||
| Bacteria | 84 | 62.7 | 35 | 72.9 | 49 | 57.0 | 0.093 | |
| 78 | 58.2 | 16 | 33.3 | 62 | 72.1 | < 0.001 | ||
| 22 | 16.4 | 11 | 22.9 | 11 | 12.8 | 0.149 | ||
| 22 | 16.4 | 5 | 10.4 | 17 | 19.8 | 0.225 | ||
| 8 | 6.0 | 3 | 6.3 | 5 | 5.8 | 1.000 | ||
| 7 | 5.2 | 2 | 4.2 | 5 | 5.8 | 1.000 | ||
| 4 | 3.0 | 2 | 4.2 | 2 | 2.3 | 0.617 | ||
| Viruses | Rhinovirus | 30 | 22.4 | 7 | 14.6 | 23 | 26.7 | 0.132 |
| Influenza B (PCR/FT) | 16 | 11.9 | 5 | 10.4 | 11 | 12.8 | 0.786 | |
| Coronavirus 229 | 7 | 5.2 | 0 | 0.0 | 7 | 8.1 | 0.050 | |
| Adenovirus | 4 | 3.0 | 0 | 0.0 | 4 | 4.7 | 0.296 | |
| Influenza A H3 (PCR/FT) | 4 | 3.0 | 4 | 8.3 | 0 | 0.0 | 0.015 | |
| Coronavirus HKU1 | 3 | 2.2 | 3 | 6.3 | 0 | 0.0 | 0.044 | |
| Coronavirus 63 | 2 | 1.5 | 0 | 0.0 | 2 | 2.3 | 0.537 | |
| Parainfluenza 2 | 2 | 1.5 | 0 | 0.0 | 2 | 2.3 | 0.537 | |
| Parainfluenza 4 | 2 | 1.5 | 0 | 0.0 | 2 | 2.3 | 0.537 | |
| Coronavirus 43 | 1 | 0.7 | 1 | 2.1 | 0 | 0.0 | 0.358 | |
| Negative | – | 6 | 4.5 | 5 | 10.4 | 1 | 1.2 | 0.022 |
ILI = influenza-like illness; PCR = polymerase chain reaction; URI = upper respiratory illness.
Fisher’s exact test comparing ILI and non-ILI cases.
Tests positive by either reverse transcription polymerase chain reaction or Fast Track multiplex PCR.
Figure 2.Pathogens detected in upper respiratory illness (URI) cases by camp, training cohort, and day of onset relative to the start of follow-up. Size and color of circles indicate number of URI cases in which a given pathogen was detected. This figure appears in color at
Influenza seroconversion rates per 100 person-months among two cohorts of Royal Thai Army recruits entering basic training
| Influenza strain | Cohort 1 | Cohort 2 | Total ( | |||
|---|---|---|---|---|---|---|
| Rate (95% CI) | Rate (95% CI) | Rate (95% CI) | ||||
| 0 | – | 2 | 0.75 (0.19; 3.00) | 2 | 0.52 (0.13; 2.09) | |
| 1 | 0.87 (0.12; 6.15) | 2 | 0.75 (0.19; 3.00) | 3 | 0.78 (0.25; 2.43) | |
| 0 | – | 7 | 2.62 (1.25; 5.50) | 7 | 1.83 (0.87; 3.84) | |
| A (unclassified) | 0 | – | 1 | 0.37 (0.05; 2.66) | 1 | 0.26 (0.04; 1.86) |
| Any | 1 | 0.87 (0.12; 6.15) | 12 | 4.50 (2.55; 7.92) | 13 | 3.40 (1.97; 5.86) |
CI = confidence interval.
November 1, 2014–January 9, 2015.
May 1, 2015–July 9, 2015.
Figure 3.Distribution of antibody titers as measured by hemagglutinin inhibition assay at baseline (y axis) and follow-up (x axis). The color scale indicates the proportion of sample pairs in each titer combination. Gray squares denote a ≥ 4-fold increase in antibody titer at follow-up. Row totals indicate the probability distribution of baseline titers. This figure appears in color at